EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Neoadjuvant SBRT and intraoperative electron radiotherapy in pancreatic cancer resection

Gianella Cornejo, Alon Pikarsky, Ayala Hubert, Marc Wygoda, Antoni Skripai, Aron Popovtzer, Jon Feldman, Yair Hillman, Liat Appelbaum, Mark Temper, Abed Khalaileh, Ashraf Imam und 2 weitere

Journal of Cancer Research and Clinical Oncology · 22.12.2025 · 152 (1)

DOI: 10.1007/s00432-025-06397-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 22.12.2025. Verfasst von Gianella Cornejo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Radiosurgery, Electrons, Adenocarcinoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/OBJECTIVES: Pancreatic cancer surgery frequently results in positive margins and local recurrence despite multimodal treatment. This study evaluated whether combining neoadjuvant stereotactic body radiotherapy (SBRT) with intraoperative electron radiotherapy (IOeRT) during resection could improve local control and surgical outcomes. METHODS: A retrospective analysis was performed on 15 patients with resectable or borderline resectable pancreatic adenocarcinoma treated between 2021 and 2023. All patients received image-guided, motion-managed SBRT (35-40 Gy/5 fractions to PTV_high; 25 Gy/5 fractions to PTV_low) followed by surgical resection and IOeRT (median 10 Gy; 12 Gy when margins were at risk). Toxicities were graded by CTCAE v5.0 and postoperative complications by Clavien-Dindo criteria. Follow-up included imaging and CA 19-9 every 3 months. Survival was estimated using Kaplan-Meier analysis. RESULTS: Mean patient age was 66 years; 60% had tumors in the pancreatic body and 40% in the head. Two-thirds were borderline resectable and received neoadjuvant chemotherapy. Margin-negative resection was achieved in 86.7%, including two complete pathologic responses in BRCA2-mutated tumors. Median overall and progression-free survival were 30 and 16 months, respectively. One patient (6.7%) developed isolated local recurrence, while distant metastases occurred in over half. Toxicities were mainly grade 1-2 fatigue, nausea, or pain; surgical complications were grade 1-2 in 53%, grade 3 in 7%, and grade 5 in 7%. CONCLUSIONS: Neoadjuvant SBRT with IOeRT during pancreatic cancer resection is feasible, achieves high rates of negative margins, and provides promising local control. Distant progression remains the dominant mode of failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsRadiosurgeryElectronsAdenocarcinomaHumansAgedMaleFemaleRetrospective StudiesNeoadjuvant TherapyMiddle AgedAged, 80 and overCombined Modality Therapy

Stichwörter der Autor:innen

Intraoperative electron radiotherapy (IOeRT)Pancreatic cancer resectionStereotactic body radiotherapy (SBRT)

Autor:innen und Institutionen

  • Department of Surgery, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Medical Oncology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Radiation Oncology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Radiology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Radiation Oncology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel. philipb@hadassah.org.il.

Zitieren

APA

Cornejo, G., Pikarsky, A., Hubert, A., Wygoda, M., Skripai, A., Popovtzer, A., Feldman, J., Hillman, Y., Appelbaum, L., Temper, M., Khalaileh, A., Imam, A., Zamir, G., & Blumenfeld, P. (2025). Neoadjuvant SBRT and intraoperative electron radiotherapy in pancreatic cancer resection. Journal of Cancer Research and Clinical Oncology, 152(1). https://doi.org/10.1007/s00432-025-06397-2

Vancouver

Cornejo G, Pikarsky A, Hubert A, Wygoda M, Skripai A, Popovtzer A, et al. Neoadjuvant SBRT and intraoperative electron radiotherapy in pancreatic cancer resection. Journal of Cancer Research and Clinical Oncology. 2025;152(1). doi:10.1007/s00432-025-06397-2

BibTeX
@article{Cornejo2025,
  author = {Cornejo, Gianella and Pikarsky, Alon and Hubert, Ayala and Wygoda, Marc and Skripai, Antoni and Popovtzer, Aron and Feldman, Jon and Hillman, Yair and Appelbaum, Liat and Temper, Mark and Khalaileh, Abed and Imam, Ashraf and Zamir, Gideon and Blumenfeld, Philip},
  title = {Neoadjuvant SBRT and intraoperative electron radiotherapy in pancreatic cancer resection},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2025},
  volume = {152},
  number = {1},
  doi = {10.1007/s00432-025-06397-2}
}
Kostenlos starten →